125 related articles for article (PubMed ID: 37160699)
1. Reconnoitering imidazopyridazines as anticancer agents based on virtual modelling approach: quantitative structure activity relationship, molecular docking and molecular dynamics.
Mangala K; Vinayak W; Aasiya C; Chandrakant B; Amol M; Kumar D; Kulkarni R
J Biomol Struct Dyn; 2024 Mar; 42(5):2392-2409. PubMed ID: 37160699
[TBL] [Abstract][Full Text] [Related]
2. Computational modelling strategies in exploring triazolopyridazine PIM1 kinase inhibitors as anticancer agents.
Walhekar V; Bagul C; Kumar D; Achaiah G; Muthal A; Kulkarni R; Basavarju M
Anticancer Agents Med Chem; 2022 Aug; ():. PubMed ID: 35993476
[TBL] [Abstract][Full Text] [Related]
3. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor (FGFR) inhibitors as anticancer agents: 3D-QSAR, molecular docking and dynamics simulation studies of 1, 6-naphthyridines and pyridopyrimidines.
Modh DH; Modi SJ; Deokar H; Yadav S; Kulkarni VM
J Biomol Struct Dyn; 2023 May; 41(8):3591-3606. PubMed ID: 35318898
[TBL] [Abstract][Full Text] [Related]
5. Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors.
Peddi SR; Peddi SR; Sivan S; Veerati R; Manga V
J Recept Signal Transduct Res; 2020 Feb; 40(1):1-14. PubMed ID: 31931654
[TBL] [Abstract][Full Text] [Related]
6.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel inhibitors for Pim-1 kinase using pharmacophore modeling based on a novel method for selecting pharmacophore generation subsets.
Shahin R; Swellmeen L; Shaheen O; Aboalhaija N; Habash M
J Comput Aided Mol Des; 2016 Jan; 30(1):39-68. PubMed ID: 26685860
[TBL] [Abstract][Full Text] [Related]
8. Structural insights for rational design of new PIM-1 kinase inhibitors based on 3,5-disubstituted indole derivatives: An integrative computational approach.
Razmazma H; Ebrahimi A; Hashemi M
Comput Biol Med; 2020 Mar; 118():103641. PubMed ID: 32174320
[TBL] [Abstract][Full Text] [Related]
9.
Akabli T; Toufik H; Lamchouri F
J Biomol Struct Dyn; 2022 Jun; 40(9):3965-3978. PubMed ID: 33252029
[TBL] [Abstract][Full Text] [Related]
10. Molecular docking-based classification and systematic QSAR analysis of indoles as Pim kinase inhibitors.
Kalaki Z; Asadollahi-Baboli M
SAR QSAR Environ Res; 2020 May; 31(5):399-419. PubMed ID: 32319325
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.
Tripathy S; Azam MA; Jupudi S; Sahu SK
J Biomol Struct Dyn; 2018 Sep; 36(12):3218-3230. PubMed ID: 28938860
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies.
Swamy P M G; Abbas N; Dhiwar PS; Singh E; Ghara A; Das A
J Biomol Struct Dyn; 2023 Jan; 41(1):125-146. PubMed ID: 34809538
[TBL] [Abstract][Full Text] [Related]
13. Design of Novel IRAK4 Inhibitors Using Molecular Docking, Dynamics Simulation and 3D-QSAR Studies.
Bhujbal SP; He W; Hah JM
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234844
[TBL] [Abstract][Full Text] [Related]
14. Simulation studies, 3D QSAR and molecular docking on a point mutation of protein kinase B with flavonoids targeting ovarian Cancer.
Ajjarapu SM; Tiwari A; Taj G; Singh DB; Singh S; Kumar S
BMC Pharmacol Toxicol; 2021 Nov; 22(1):68. PubMed ID: 34727985
[TBL] [Abstract][Full Text] [Related]
15. 2D- and 3D-QSAR modelling, molecular docking and
Shukla A; Tyagi R; Meena S; Datta D; Srivastava SK; Khan F
J Biomol Struct Dyn; 2020 Jan; 38(1):168-185. PubMed ID: 30686140
[TBL] [Abstract][Full Text] [Related]
16. QSAR Study, Molecular Docking and Molecular Dynamic Simulation of Aurora Kinase Inhibitors Derived from Imidazo[4,5-
Tian YY; Tong JB; Liu Y; Tian Y
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675594
[TBL] [Abstract][Full Text] [Related]
17. Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation.
Ibrahim MH; Harras MF; Mostafa SK; Mohyeldin SM; Al Kamaly O; Altwaijry N; Sabour R
Bioorg Chem; 2022 Dec; 129():106122. PubMed ID: 36084418
[TBL] [Abstract][Full Text] [Related]
18. Binding site identification and role of permanent water molecule of PIM-3 kinase: A molecular dynamics study.
Ul-Haq Z; Gul S; Usmani S; Wadood A; Khan W
J Mol Graph Model; 2015 Nov; 62():276-282. PubMed ID: 26529487
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
20. 3D QSAR studies, molecular docking and ADMET evaluation, using thiazolidine derivatives as template to obtain new inhibitors of PIM1 kinase.
Aouidate A; Ghaleb A; Ghamali M; Ousaa A; Choukrad M; Sbai A; Bouachrine M; Lakhlifi T
Comput Biol Chem; 2018 Jun; 74():201-211. PubMed ID: 29635214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
